Literature DB >> 14643452

Isolation of lung tumor specific peptides from a random peptide library: generation of diagnostic and cell-targeting reagents.

Tsuksa Oyama1, Kathryn F Sykes, Kausar N Samli, John D Minna, Stephen Albert Johnston, Kathlynn C Brown.   

Abstract

Discovery of ligands specific to receptor(s) on a surface of a cancer cell could impact clinical issues including functional diagnosis and cell-specific drug delivery. Using a phage display approach, we have isolated 20-mer peptide ligands that bind to 3 different human lung tumor cell lines, NCI-H1299, NCI-H2009, and A549. The panning protocol is unbiased with no selection pressure towards binding a particular cellular receptor. The isolated phage bind to their target cells 24-300 times better than a control phage. Furthermore, the isolated peptides display remarkable cell-specificities and are able to discriminate between normal and cancerous cells as well as different lung tumor cells. The cell-specificities are not coincident with tumor classes indicating that the peptides are able to recognize cell-surface features that are not represented within the classification of tumor type. The isolated peptides are functional outside of the context of the phage and multimerization of the peptide increases its affinity for its given cell type, thus expanding their utility in clinical situations.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14643452     DOI: 10.1016/j.canlet.2003.08.011

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  41 in total

Review 1.  Peptides in cancer nanomedicine: drug carriers, targeting ligands and protease substrates.

Authors:  Xiao-Xiang Zhang; Henry S Eden; Xiaoyuan Chen
Journal:  J Control Release       Date:  2011-10-26       Impact factor: 9.776

2.  A Novel Strategy for Surface Modification of Superparamagnetic Iron Oxide Nanoparticles for Lung Cancer Imaging.

Authors:  Gang Huang; Chunfu Zhang; Shunzi Li; Chalermchai Khemtong; Su-Geun Yang; Ruhai Tian; John D Minna; Kathlynn C Brown; Jinming Gao
Journal:  J Mater Chem       Date:  2009

3.  Molecular imaging and therapy -- a programme based on the development of new biomolecules.

Authors:  Uwe Haberkorn; Michael Eisenhut
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-12       Impact factor: 9.236

4.  In vivo phage display selection yields atherosclerotic plaque targeted peptides for imaging.

Authors:  Kimberly A Kelly; Matthias Nahrendorf; Amy M Yu; Fred Reynolds; Ralph Weissleder
Journal:  Mol Imaging Biol       Date:  2006 Jul-Aug       Impact factor: 3.488

Review 5.  Combinatorial peptide libraries: mining for cell-binding peptides.

Authors:  Bethany Powell Gray; Kathlynn C Brown
Journal:  Chem Rev       Date:  2013-12-03       Impact factor: 60.622

Review 6.  Darwinian molecular imaging.

Authors:  Bertrand Tavitian; Uwe Haberkorn
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-09       Impact factor: 9.236

Review 7.  High-Throughput Approaches to the Development of Molecular Imaging Agents.

Authors:  Lina Y Hu; Kimberly A Kelly; Julie L Sutcliffe
Journal:  Mol Imaging Biol       Date:  2017-04       Impact factor: 3.488

Review 8.  Virus-Derived Peptides for Clinical Applications.

Authors:  Mingying Yang; Kegan Sunderland; Chuanbin Mao
Journal:  Chem Rev       Date:  2017-07-19       Impact factor: 60.622

9.  Discovery of high-affinity protein binding ligands--backwards.

Authors:  Chris W Diehnelt; Miti Shah; Nidhi Gupta; Paul E Belcher; Matthew P Greving; Phillip Stafford; Stephen Albert Johnston
Journal:  PLoS One       Date:  2010-05-19       Impact factor: 3.240

10.  Isolation of osteosarcoma-associated human antibodies from a combinatorial Fab phage display library.

Authors:  Carmela Dantas-Barbosa; Fabrícia P Faria; Marcelo M Brigido; Andrea Q Maranhão
Journal:  J Biomed Biotechnol       Date:  2009-12-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.